Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Victhom Human Bionics Inc V.VHB



TSXV:VHB - Post by User

Bullboard Posts
Post by JABombardieron Feb 16, 2009 10:37pm
179 Views
Post# 15782181

Victhom (VHB) Nice adds on Marketwatch....

Victhom (VHB) Nice adds on Marketwatch....

https://www.marketwatch.com/news/story/just-three-weeks-left-register/story.aspx?guid=%7B9BAB5B87-E963-4750-BE86-A50D6A0255F0%7D&dist=msr_2

Just Three Weeks Left to Register for the Ultimate Device Partnering Conference - "Investment In Innovation (In3) West" Conference, March 2-4, 2009, Las Vegas, NV


Last update: 12:02 p.m. EST Feb. 9, 2009
IRVINE, Calif., Feb 09, 2009 (BUSINESS WIRE) -- Medtech Insight, a division of Windhover Conferences, an Elsevier company, and a leading provider of business information for the medical device industry, has announced that over 40 early- to late-stage companies are now confirmed to present at their upcoming "Investment In Innovation (In3) West" conference, being held March 2-4, 2009 at The Palazzo Resort a- Hotel a- Casino in Las Vegas, NV. Presentation timeslots are limited for this popular event, designed for those looking to partner, invest and network with the most promising start-up medical technology companies on course to impact the worldwide med device market.
The two-day In3 West event - the company's 33rd In3 conference - will showcase 40+ highly promising start-up med device companies from around the world, presenting to an audience of senior business development and investment executives from the leading medical technology and healthcare investment firms worldwide, for purposes of raising funding or forming strategic partnerships. Presenting companies (the majority presenting at an In3 event for the first time) from the U.S., Canada, Europe and Israel include
latest news
PRESS RELEASE

Just Three Weeks Left to Register for the Ultimate Device Partnering Conference - "Investment In Innovation (In3) West" Conference, March 2-4, 2009, Las Vegas, NV


Last update: 12:02 p.m. EST Feb. 9, 2009
IRVINE, Calif., Feb 09, 2009 (BUSINESS WIRE) -- Medtech Insight, a division of Windhover Conferences, an Elsevier company, and a leading provider of business information for the medical device industry, has announced that over 40 early- to late-stage companies are now confirmed to present at their upcoming "Investment In Innovation (In3) West" conference, being held March 2-4, 2009 at The Palazzo Resort a- Hotel a- Casino in Las Vegas, NV. Presentation timeslots are limited for this popular event, designed for those looking to partner, invest and network with the most promising start-up medical technology companies on course to impact the worldwide med device market.
The two-day In3 West event - the company's 33rd In3 conference - will showcase 40+ highly promising start-up med device companies from around the world, presenting to an audience of senior business development and investment executives from the leading medical technology and healthcare investment firms worldwide, for purposes of raising funding or forming strategic partnerships. Presenting companies (the majority presenting at an In3 event for the first time) from the U.S., Canada, Europe and Israel include
Athena Feminine Technologies, Inc., Intralink-Spine (ILS), Silere Medical Technology, Inc.,Audition Biotech LLC, Kuros Biosurgery, AG, Sleepvirtual,Bioheart, Inc., LifeWave, Inc., Soft Tissue Regeneration, Inc. (TM),BioLineRx, Ltd., LineaGen, Inc., superDimension, Inc.,Celerus Diagnostics, Inc., Mesynthes, Tagent,CVAC Systems, Inc., MicroTransponder, Inc., ThromboVision, Inc.,CytoSorbents, Inc., Nanospectra Biosciences, Inc., TrueVision Systems Inc.,Deep Vein Medical, NeoMend, Inc., Urovalve, Inc.,Discovery Technology International, LLP, Nerites Corporation, Vertos Medical, Inc.e-Zassi, LLC, NuLens, Ltd., VG Innovations, LLC,FAST Diagnostics, PEAK Surgical, Inc., Victhom Human Bionics, Inc.,Freedom Meditech Inc., pico-tesla Magnetic Therapies, LLC, ViOptix Inc.,Genesis Medical Interventional, Inc., Polymedix, Inc., Zassi Medical Evolutions, LLC.Healionics Corporation, Prizm Medical, Inc., ... among several others to be announced.Infopia USA, S.E.A. Medical Systems, Inc.,Intellewave, LLC, Sensile Medical AG, Sequoia Medtech, Sherlock-NMD,              

Bullboard Posts